Tuen Mun Hospital
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1990-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www3.ha.org.hk/tmh/en
Clinical Trials
23
Active:0
Completed:18
Trial Phases
2 Phases
Phase 4:13
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (15 trials with phase data)• Click on a phase to view related trials
Phase 4
13 (86.7%)Not Applicable
2 (13.3%)Dialysis Efficiency and Transporter Evaluation Computational Tool in Peritoneal Dialysis
- Conditions
- End-Stage Kidney DiseaseEnd Stage Renal Disease on Dialysis (Diagnosis)Peritoneal DialysisPeritoneal Dialysis PatientsEnd Stage Renal Disease (ESRD)End Stage Renal Failure on Dialysis
- First Posted Date
- 2025-02-24
- Last Posted Date
- 2025-04-09
- Lead Sponsor
- Tuen Mun Hospital
- Target Recruit Count
- 350
- Registration Number
- NCT06842927
- Locations
- 🇭🇰
Tuen Mun Hospital, Tuen Mun, Hong Kong
Romosozumab Versus Denosumab in GIOP: a 2-year Extension Study
Phase 4
Recruiting
- Conditions
- OsteoporosisGlucocorticoids Toxicity
- Interventions
- First Posted Date
- 2024-06-24
- Last Posted Date
- 2024-11-22
- Lead Sponsor
- Tuen Mun Hospital
- Target Recruit Count
- 63
- Registration Number
- NCT06472050
- Locations
- 🇨🇳
Department of Medicine, Tuen Mun Hospital, Hong Kong, China
Virtual Reality to Reduce Anxiety and Pain During Suturing Procedure
Not Applicable
Completed
- Conditions
- Suture
- First Posted Date
- 2023-04-03
- Last Posted Date
- 2024-04-16
- Lead Sponsor
- Tuen Mun Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT05796076
- Locations
- 🇭🇰
Tuen Mun Hospital-Emergency department, Hong Kong, Hong Kong
Safety and Retention Rate of the JAK and TNF Inhibitors in Rheumatoid Arthritis: a Real-life Experience
Completed
- Conditions
- Rheumatoid ArthritisDrug Use
- Interventions
- Drug: biologic/targeted therapy
- First Posted Date
- 2022-01-10
- Last Posted Date
- 2023-02-22
- Lead Sponsor
- Tuen Mun Hospital
- Target Recruit Count
- 1732
- Registration Number
- NCT05182203
- Locations
- 🇨🇳
Department of Medicine, Tuen Mun Hospital, Hong Kong, China
Shingrix in Patients With Rheumatic Diseases: a Double-blind Placebo-controlled RCT
Phase 4
Not yet recruiting
- Conditions
- Herpes Zoster
- First Posted Date
- 2021-02-10
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- Tuen Mun Hospital
- Target Recruit Count
- 140
- Registration Number
- NCT04748939
- Locations
- 🇨🇳
Department of Medicine, Tuen Mun Hospital, Hong Kong, China
- Prev
- 1
- 2
- 3
- 4
- 5
- Next
News
No news found